The Profile of Ocular Fibrous Histiocytoma Tumors at Dr. M. Djamil General Hospital, Padang, Indonesia
DOI:
https://doi.org/10.37275/bsm.v6i17.716Keywords:
Excision, Fibroblastic cells, Histiocytic cells, Ocular fibrous histiocytoma, EyelidAbstract
Background: Ocular fibrous histiocytoma tumors originate from histiocytic cells or primitive mesenchymal cells. A fibrous histiocytoma is basically composed of a mixture of fibroblastic cells, histiocytes, blood vessels, and collagen in various proportions. This study aimed to determine the profile of ocular fibrous histiocytoma tumors at Dr. M. Djamil General Hospital, Padang, Indonesia.
Methods: This study was a descriptive observational study. A total of 8 research subjects participated in this study. Data analysis was carried out with the help of SPSS version 24 software, and univariate analysis was carried out.
Results: The majority of subjects were female, with an age range of 41-60 years. The clinical symptoms felt by patients are the presence of a mass. The majority of study subjects had disease onset < 6 months, and tumor sizes were 1-5 cm. The majority of tumor locations are on the eyelid, and the histopathologic overview shows xanthelasma and dermatofibromas. Excision therapy is the therapy for the majority of research subjects.
Conclusion: Most types of fibrous histiocytoma tumors at Dr. M. Djamil General Hospital, Padang, Indonesia, are benign type and locally aggressive.
Authors
- Eka Alpasra1*
- Ardizal Rahman1
- Mardijas Efendi1
- 1Department of Ophthalmology, Faculty of Medicine, Universitas Andalas/Dr. M. Djamil General Hospital, Padang, Indonesia
Corresponding author Eka Alpasra — ekaalpasra@yahoo.co.id
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
